Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Genetics of Schizophrenia
This study is not yet open for participant recruitment.
Verified by Sheba Medical Center, February 2008
Sponsored by: Sheba Medical Center
Information provided by: Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00619437
  Purpose

Genetic etiology in schizophrenia is widely accepted. However, many chromosomal sites were shown to characterize the families of patients with schizophrenia. This is probably due to the high genetic heterogenity of this illness. Thus, it is important to investigate the genetic factor in relatively genetically homogenous populations. Many studies have indicate that Ashkenazy Jews show relative gentic homogenity. Indeed, the genes responsible for most Mendelian disorders of Jewish peoples have been identified. The study will apply genome-wide mutation screening methods to identify candidate allells in subjects of Ashkenazi Jewish ancestry with multiplex schizophrenia.


Condition
Schizophrenia

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources
Study Type: Observational
Study Design: Family-Based, Prospective
Official Title: Genetics of Schizophrenia

Further study details as provided by Sheba Medical Center:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Cell Lines / DNA


Estimated Enrollment: 100
Study Start Date: April 2008
Estimated Study Completion Date: December 2009
  Eligibility

Ages Eligible for Study:   18 Years to 78 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

schizophrenia

Criteria

Inclusion Criteria:

  1. Age 18+;
  2. Meet DSM-IV criteria for Schizophrenia;
  3. At least one first-degree relative who Meet DSM-IV criteria for Schizophrenia;
  4. Can sign the informed consent form.

Exclusion Criteria:

  1. Patients suffering from terminal or incurabale disease;
  2. Minors, incompetents
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00619437

Contacts
Contact: Raz Gross, MD, MPH 972 3 530 3962 razg@gertner.health.gov.il

Locations
Israel
Sheba Medical Center
Tel Hashomer, Israel
Sponsors and Collaborators
Sheba Medical Center
Investigators
Study Director: Michael Bunzel, MD Psychiatric ward, Sheba Medical Center
  More Information

Responsible Party: Mental Health Epidemiology, The Gertner Institute for Epidemiology ( Raz Gross, Head )
Study ID Numbers: SHEBA-07-4620-RG-CTIL
Study First Received: February 10, 2008
Last Updated: February 10, 2008
ClinicalTrials.gov Identifier: NCT00619437  
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
schizophrenia
genetics
family
multiplex
haplotypes

Study placed in the following topic categories:
Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on January 16, 2009